Campath and Morphine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Campath (alemtuzumab) and Morphine (morphine sulfate). Common drug interactions include death among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Campath and Morphine. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Campath?

Campath has active ingredients of alemtuzumab. eHealthMe is studying from 4,909 Campath users. Check the latest studies of Campath.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,914 Morphine users. Check the latest studies of Morphine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

43 people who take Campath and Morphine together, and have interactions are studied.

Campath and Morphine drug interactions.

What are the common drug interactions of Campath and Morphine, by gender? *:

female:

  1. Death
  2. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  3. Septic shock (shock due to blood infection)
  4. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  5. Blood bilirubin increased
  6. Blood culture positive
  7. Diarrhoea
  8. Diarrhoea haemorrhagic (bloody diarrhoea)
  9. Gamma-glutamyltransferase increased
  10. Haematoma (collection of blood outside the blood vessels)

male:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Cough
  4. Cystitis (inflammation of the wall of the bladder)
  5. Dysuria (painful or difficult urination)
  6. Jc virus infection
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Pelvic pain
  9. Platelet count decreased
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the common drug interactions of Campath and Morphine, by age (0-1 to 60+)? *:

0-1:

  1. Langerhans' cell histiocytosis
  2. Cardiogenic shock (inadequate circulation of blood)

2-9:

  1. Acinetobacter infection (infection by group of bacteria commonly found in soil and water)
  2. Diarrhoea
  3. Diarrhoea haemorrhagic (bloody diarrhoea)
  4. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Pleural effusion (water on the lungs)
  7. Pyrexia (fever)
  8. Septic shock (shock due to blood infection)
  9. Tooth abscess (pus formation in tooth)

10-19:

  1. Post procedural haemorrhage (post procedural bleeding)
  2. Post procedural urine leak
  3. Pyrexia (fever)
  4. Thrombocytopenia (decrease of platelets in blood)
  5. Sinusitis (inflammation of sinus)

20-29:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Pneumonia necrotising (necrotizing pneumonia is a life-threatening condition in which a person breathes material into his or her lungs)
  4. Serratia infection (bacterial infection)
  5. Abdominal pain
  6. Adenoviral haemorrhagic cystitis
  7. Adenovirus infection
  8. Aspartate aminotransferase increased
  9. Bk virus infection
  10. Bladder disorder

30-39:

  1. Blood glucose increased
  2. Blood urea increased
  3. Liver transplant rejection (failure of liver transplant)
  4. Marrow hyperplasia (increased bone marrow)
  5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

40-49:

  1. Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
  2. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  3. Asthma
  4. Hypoaesthesia (reduced sense of touch or sensation)
  5. Muscular weakness (muscle weakness)
  6. Pain in extremity

50-59:

  1. Impaired healing
  2. Infection
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Osteomyelitis (infection of bone)
  5. Osteonecrosis (death of bone)
  6. Pain in jaw
  7. Pharyngolaryngeal pain
  8. Procedural hypotension
  9. Pulmonary oedema (fluid accumulation in the lungs)
  10. Renal failure acute (rapid kidney dysfunction)

60+:

  1. Decreased appetite
  2. Pneumonia
  3. Abdominal wound dehiscence (abdominal wound ruptures)
  4. Brain neoplasm (tumour of brain)
  5. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  6. Depressed level of consciousness
  7. Haemoglobin decreased
  8. Incisional hernia (hernia caused by an incompletely-healed surgical wound)
  9. Lymphoma (cancer that begins in immune system cells)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 18 people, 41.86%
  2. Glaucoma (increased fluid pressure in the eye with vision loss): 13 people, 30.23%
  3. Hair Loss: 11 people, 25.58%
  4. Abdominal Pain: 5 people, 11.63%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.30%
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 4 people, 9.30%
  7. Asthma: 4 people, 9.30%
  8. Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 4 people, 9.30%
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 4 people, 9.30%
  10. Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Campath and Morphine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Campath and Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Campath:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Campath and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on alemtuzumab and morphine sulfate (the active ingredients of Campath and Morphine, respectively), and Campath and Morphine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: